196 related articles for article (PubMed ID: 17561234)
1. Coexpression index of estrogen receptor alpha mRNA isoforms in simple, complex hyperplasia without atypia, complex atypical hyperplasia and adenocarcinoma.
Witek A; Paul-Samojedny M; Stojko R; Seifert B; Mazurek U
Gynecol Oncol; 2007 Aug; 106(2):407-12. PubMed ID: 17561234
[TBL] [Abstract][Full Text] [Related]
2. Expression of receptor-binding cancer antigen expressed on SiSo cells and estrogen receptor subtypes in the normal, hyperplastic, and carcinomatous endometrium.
Zhou XH; Teng XD; Song WY; Wu YJ
Int J Gynecol Cancer; 2008; 18(1):152-8. PubMed ID: 17466050
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of wild-type estrogen receptor beta and its isoforms: ER-beta/delta 5/6 i ER-beta/delta 6 in endometrial adenocarcinoma].
Witek A; Skałba P; Paul M; Graniczka M; Mazurek U; Chromy G; Wilczok T
Ginekol Pol; 2003 Sep; 74(9):897-902. PubMed ID: 14674142
[TBL] [Abstract][Full Text] [Related]
4. Cellular retinol binding protein-1 expression in endometrial hyperplasia and carcinoma: diagnostic and possible therapeutic implications.
Orlandi A; Ferlosio A; Ciucci A; Francesconi A; Lifschitz-Mercer B; Gabbiani G; Spagnoli LG; Czernobilsky B
Mod Pathol; 2006 Jun; 19(6):797-803. PubMed ID: 16575402
[TBL] [Abstract][Full Text] [Related]
5. [Profile of estrogen receptor alpha isoforms in endometrial adenocarcinoma].
Witek A; Skałba P; Paul M; Stojko R; Nawrocki M; Mazurek U; Wilczok T
Ginekol Pol; 2003 Sep; 74(9):903-10. PubMed ID: 14674143
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor alpha mRNA variant lacking exon 5 is co-expressed with the wild-type in endometrial adenocarcinoma.
Cobellis L; Reis FM; Driul L; Vultaggio G; Ferretti I; Villa E; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2002 Apr; 102(1):92-5. PubMed ID: 12039098
[TBL] [Abstract][Full Text] [Related]
7. Differential Expression of IR-A, IR-B and IGF-1R in Endometrial Physiology and Distinct Signature in Adenocarcinoma.
Flannery CA; Saleh FL; Choe GH; Selen DJ; Kodaman PH; Kliman HJ; Wood TL; Taylor HS
J Clin Endocrinol Metab; 2016 Jul; 101(7):2883-91. PubMed ID: 27088794
[TBL] [Abstract][Full Text] [Related]
8. Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma.
Xu JY; Zhu WJ; Cao XZ; Li XF; Wu J
Int J Gynecol Cancer; 2011 Apr; 21(3):430-4. PubMed ID: 21436690
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta1 and the beta2/betacx isoforms in nonneoplastic endometrium and in endometrioid carcinoma.
Chakravarty D; Srinivasan R; Ghosh S; Gopalan S; Rajwanshi A; Majumdar S
Int J Gynecol Cancer; 2007; 17(4):905-13. PubMed ID: 17309672
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein 4 overexpression in endometrial carcinoma and upregulation by estrogen via mitogen-activated protein kinase signal pathway.
Zhang SQ; Cai B; Liu L; He YY; Yang YX; Wan XP
Int J Gynecol Cancer; 2009 Nov; 19(8):1377-83. PubMed ID: 20009893
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
Chakravarty D; Srinivasan R; Ghosh S; Rajwanshi A; Gopalan S
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):535-42. PubMed ID: 18931615
[TBL] [Abstract][Full Text] [Related]
12. Production of activin A in hyperplasia and adenocarcinoma of the human endometrium.
Otani T; Minami S; Yamoto M; Umesaki N
Gynecol Oncol; 2001 Oct; 83(1):31-8. PubMed ID: 11585411
[TBL] [Abstract][Full Text] [Related]
13. Significance of hormone receptor status and tumor vessels in normal, hyperplastic and neoplastic endometrium.
Nunobiki O; Taniguchi E; Ishii A; Tang W; Utsunomiya H; Nakamura Y; Mori I; Kakudo K
Pathol Int; 2003 Dec; 53(12):846-52. PubMed ID: 14629750
[TBL] [Abstract][Full Text] [Related]
14. Expression of androgen receptor and 5alpha-reductases in the human normal endometrium and its disorders.
Ito K; Suzuki T; Akahira J; Moriya T; Kaneko C; Utsunomiya H; Yaegashi N; Okamura K; Sasano H
Int J Cancer; 2002 Jun; 99(5):652-7. PubMed ID: 12115497
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of c-myc, c-jun and estrogen receptor in normal, hyperplastic and neoplastic endometrium.
Bircan S; Ensari A; Ozturk S; Erdogan N; Dundar I; Ortac F
Pathol Oncol Res; 2005; 11(1):32-9. PubMed ID: 15800680
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptor beta delta 6 (ER beta delta 6) isoform in human endometrial hyperplasia and adenocarcinoma.
Paul M; Cholewa K; Mazurek U; Witek A; Wilczok T
Cancer Invest; 2004; 22(2):211-8. PubMed ID: 15199603
[TBL] [Abstract][Full Text] [Related]
17. [MMP-26 mRNA and estrogen receptor alpha co-expression in normal and pathological endometrium].
Pilka R; Kudela M; Eriksson P; Casslén B
Ceska Gynekol; 2005 Jan; 70(1):56-62. PubMed ID: 15779297
[TBL] [Abstract][Full Text] [Related]
18. Heart and Neural Crest Derivatives Expressed Transcript 2 (HAND2): a novel biomarker for the identification of atypical hyperplasia and Type I endometrial carcinoma.
Buell-Gutbrod R; Cavallo A; Lee N; Montag A; Gwin K
Int J Gynecol Pathol; 2015 Jan; 34(1):65-73. PubMed ID: 25473755
[TBL] [Abstract][Full Text] [Related]
19. Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
Balmer NN; Richer JK; Spoelstra NS; Torkko KC; Lyle PL; Singh M
Mod Pathol; 2006 Dec; 19(12):1593-605. PubMed ID: 16980945
[TBL] [Abstract][Full Text] [Related]
20. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]